$15.38
Today
as of Jul 22, 16:47 ET
Last 30 days
Recent Press Releases & News
Caris Life Sciences (CAI) Stock Looks Undervalued On A 47% Slump
Caris Life Sciences (CAI) Sets August Results Date, Is The Stock Undervalued?
Caris Life Sciences (CAI) Launches In House PTEN Test After FDA Prostate Cancer Approval
Overview
52-week range
$14
$42
4% of range
Avg surprise (last 2)
-28.6%
Avg reaction (last 1)
+3.7%
100% positive
Latest IV / EM
85%
EM ±19.5% · $15 · Aug 21
Earnings trends
EPS — actual vs estimate
Actual Estimate
Revenue vs Net Income
Revenue Net income
Earnings history
| Date | Period | Actual EPS | Est | Surprise | YoY %Δ | Day react | Source |
|---|---|---|---|---|---|---|---|
| Thu May 7, 2026 | Mar/2026 | — | $-0.02 | +100.0% | — | +3.7% | earnings |
| Tue Sep 30, 2025 | Sep 2025 | $0.08 | — | — | — | — | financials |
| Tue Aug 12, 2025 | Jun/2025 | $-0.54 | $-0.21 | -157.1% | — | — | earnings |
| Mon Mar 31, 2025 | Mar 2025 | $-3.57 | — | — | — | — | financials |
| Mon Sep 30, 2024 | Sep 2024 | $-2.59 | — | — | — | — | financials |
| Sun Jun 30, 2024 | Jun 2024 | $-2.54 | — | — | — | — | financials |
Upcoming
| Date | Fiscal | Time | EPS Est | LY EPS | YoY %Δ |
|---|---|---|---|---|---|
| Wed Aug 5, 2026 | Jun/2026 | AMC | -$0.01 | -$0.54 | +98.2% |
Financials
Income statement (quarterly)
| Metric | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $216M | — | $217M | $181M | $121M | — | $102M | $100M |
| Cost of revenue | — | — | — | — | — | — | — | — |
| Gross profit | — | — | — | — | — | — | — | — |
| Operating income | $5M | — | $33M | $-18M | $-58M | — | $-61M | $-67M |
| Net income | $-510,000 | — | $24M | $-72M | $-103M | — | $-68M | $-66M |
| EPS (diluted) | — | — | $0.08 | $-7.97 | $-3.57 | — | $-2.59 | $-2.54 |
Balance sheet (quarterly)
| Metric | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $820M | — | $753M | $719M | $31M | $64M | — | — |
| Inventory | — | — | — | — | — | — | — | — |
| Total current assets | $1.01B | $998M | $854M | $833M | — | $216M | — | — |
| Total assets | $1.16B | $1.13B | $985M | $955M | — | $344M | — | — |
| Long-term debt | $381M | $379M | $376M | $374M | — | $319M | — | — |
| Total liabilities | $569M | $548M | $506M | $502M | — | $621M | — | — |
| Total equity | $593M | $577M | $478M | $453M | $-2.60B | $-2.50B | $-2.44B | $-2.36B |